awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33590407-40A14D0E-66A0-4FC6-A3C1-7101943981AE
Q33590407-40A14D0E-66A0-4FC6-A3C1-7101943981AE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33590407-40A14D0E-66A0-4FC6-A3C1-7101943981AE
Sorafenib combined with transarterial chemoembolization versus transarterial chemoembolization alone for advanced-stage hepatocellular carcinoma: a propensity score matching study.
P2860
Q33590407-40A14D0E-66A0-4FC6-A3C1-7101943981AE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33590407-40A14D0E-66A0-4FC6-A3C1-7101943981AE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b5b347caa1026dfe7d98b84df812de9bcb70cef3
P2860
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial